10/19/2026
We are writing this with hope in our hearts for early detection efforts to make inroads with all the diseases we work with. With the passage of the , recognized that patient access to FDA-approved tests are critical. The supportive advisory committee vote a few weeks ago marks meaningful progress in cancer screening.
An independent FDA advisory committee voted in favor of a blood test called Galleri that could identify signs of most cancers.
